Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Ingle

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
American Journal of Clinical Oncology|August 1, 1985
Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposureJ N Ingle, D M Pfeifle, S J Green, et al.
Cancer|December 1, 1994
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolL C Hartmann, J N Ingle, L E Wold, et al.
Cancer|April 1, 1989
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancerJ N Ingle, L K Everson, H S Wieand, et al.
Cancer|May 15, 1989
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancerR F Marschke, J N Ingle, D J Schaid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2002
Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statementA U Buzdar, S E Come, A Brodie, et al.
American Journal of Clinical Oncology|August 1, 1982
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapyD L Ahmann, J R O'Fallon, P W Scanlon, et al.
Lancet (London, England)|April 29, 1978
Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancerD L Ahmann, P W Scanlon, H F Bisel, et al.
The New England Journal of Medicine|January 1, 1981
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancerJ N Ingle, D L Ahmann, S J Green, et al.
Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.
The New England Journal of Medicine|April 13, 2000
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant GroupE A Stadtmauer, A O'Neill, L J Goldstein, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
American Journal of Clinical Oncology|August 1, 1985
Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposureJ N Ingle, D M Pfeifle, S J Green, et al.
Cancer|December 1, 1994
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolL C Hartmann, J N Ingle, L E Wold, et al.
Cancer|April 1, 1989
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancerJ N Ingle, L K Everson, H S Wieand, et al.
Cancer|May 15, 1989
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancerR F Marschke, J N Ingle, D J Schaid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2002
Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statementA U Buzdar, S E Come, A Brodie, et al.
American Journal of Clinical Oncology|August 1, 1982
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapyD L Ahmann, J R O'Fallon, P W Scanlon, et al.
Lancet (London, England)|April 29, 1978
Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancerD L Ahmann, P W Scanlon, H F Bisel, et al.
The New England Journal of Medicine|January 1, 1981
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancerJ N Ingle, D L Ahmann, S J Green, et al.
Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.
The New England Journal of Medicine|April 13, 2000
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant GroupE A Stadtmauer, A O'Neill, L J Goldstein, et al.
Pageof 17